Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Globus Medical › Officer exercised or converted 20K GMED derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Feb 25, 2026
Reporting period Not applicable
Filed with the SEC Feb 27, 2026 Officer Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001193125-26-083348
Filed / recorded
Feb 27, 2026, 10:53 PM UTC
Added to OQRO Oct 6, 2026, 7:37 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Kelly Huller
Officer title EVP, GC, Corporate Secretary
Security Stock Option (Right to Buy Class A Common Stock)
Table Derivative (Table II)
Transaction date Feb 25, 2026
Acquired / disposed Disposed (D)
Footnotes from the filing These options were granted on January 22, 2019 and are fully vested. The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jan 7, 2026 Company filing · Form 8-K · Results Reported its results Jan 8, 2026 Insider · 2 people Insiders: 2 sales (~$566K) Jan 13, 2026 Federal contract · $42K obligated Department of Defense awarded GLOBUS MEDICAL INC: $42K obligated to date Jan 15, 2026 Federal contract · $61K obligated Department of Defense awarded GLOBUS MEDICAL INC: $61K obligated to date Jan 22, 2026 Federal contract · $27K obligated Department of Defense awarded GLOBUS MEDICAL INC: $27K obligated to date Jan 28, 2026 Federal contract · $31K obligated Department of Defense awarded GLOBUS MEDICAL INC: $31K obligated to date Feb 12, 2026 Insider Officer sold ~$877K of GMED shares in the open market Feb 20, 2026 Federal contract · $64K obligated Department of Defense awarded GLOBUS MEDICAL INC: $64K obligated to date Feb 24, 2026 Company filing · Form 8-K · Results Reported its results Feb 25, 2026 Insider · Their largest sale since 2019 Officer sold ~$1.89M of GMED shares in the open market What came next Feb 26, 2026 Federal contract · $23K obligated Department of Defense awarded GLOBUS MEDICAL INC: $23K obligated to date Mar 3, 2026 Congress Disclosed purchase of GMED — reported range $1,001 - $15,000 Mar 10, 2026 Federal contract · $23K obligated Department of Defense awarded GLOBUS MEDICAL INC: $23K obligated to date Mar 23, 2026 Company filing · Form 8-K · Executive change, Reg FD Changed a top executive or board member, and shared information with investors “On March 23, 2026, John A. DeFord, Ph.D., a member of the Board of Directors (the “Board”) of Globus Medical, Inc. (the “Company”), informed the Company of his resignation from the Board effective immediately.”